Skip to content

Uterine Preservation versus Hysterectomy in Transvaginal Natural Orifice Transluminal Endoscopic Surgery Presacral-Uterosacral Ligament Compound Suspension for Apical Compartment Prolapse: Prospective Randomized Controlled Study

Uterine Preservation versus Hysterectomy in Transvaginal Natural Orifice Transluminal Endoscopic Surgery Presacral-Uterosacral Ligament Compound Suspension for Apical Compartment Prolapse: Prospective Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087154
Enrollment
Unknown
Registered
2024-07-22
Start date
2024-07-30
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic organ prolapse

Interventions

Group A:Uterus-preservation
Group B:hysterectomy

Sponsors

the Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients with pelvic organ prolapse treated at the Obstetrics and Gynecology Hospital of Fudan University; (2) Patients who have completed childbearing and have no desire for future pregnancies; (3) Age range of 50-70 years old; (4) Using POP-Q scoring, primary pelvic organ prolapse patients with uterine prolapse at stage II or above, (5) combined with prolapse of other pelvic organs up to the hymen edge; (6) Patients who refuse conservative treatment or have failed conservative treatment; (7) First-time pelvic organ prolapse surgery patients; (8) Patients who may have concurrent urinary incontinence; Patients willing to comply with regular postoperative follow-up.

Exclusion criteria

Exclusion criteria: Patients who subjectively reject this surgical option; Patients with a history of previous pelvic organ prolapse surgery; Patients contraindicated for uterine preservation due to conditions such as endometrial lesions, uterine or cervical tumors, etc.; Patients who have undergone previous hysterectomy; Patients with severe medical or surgical conditions, tumors, infections, or bleeding; Patients suspected or diagnosed with malignant pelvic tumors; Patients who are too old to tolerate surgery.

Design outcomes

Primary

MeasureTime frame
surgical success rate; functional recovery;

Secondary

MeasureTime frame
Perioperative primary indicators; anatomical recovery;

Countries

China

Contacts

Public ContactYisong Chen

Obstetrics and Gynecology Hospital of Fudan University

cys373900207@163.com+86 136 0191 3713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026